Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | HCID 22725090 | HCID 22725090 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 22725085 | HCID 22725085 | 76.3% |
Reaction Steps
Add piperazine (20 mg, 0.23 mmol) to a solution of the product of Step 2 (25 mg, 0.05 mmol) in EtOH (4 ml) at RT. Stir the reaction mixture at 80° C. overnight. Extract and purify to produce the title compound (20 mg). 1H NMR (CDCl3) δ8.24 (d, 1H), 7.93 (d, 2H), 7.26 (d, 2H), 7.22 (t, 2H), 7.10 (t, 2H), 6.33 (d, 1H), 5.64 (s, 1H), 3.67 (s, br, 4H), 3.15 (s, br, 2H), 2.95 (m, 4H), 2.59 (dd, 2H), 2.34 (m, 2H), 2.17 (m, 2H), 1.57 (d, br, 2H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06727254B2 |
|---|
| Source dataset | uspto-grants-2004_04 |
|---|
| ORD ID | ord-658d4231f3bb4b2dafd2d598dcd0692f |
|---|
| Source note | uspto-grants-2004_04 |
|---|